Literature DB >> 29270086

Triaging Patients with Multiple Sclerosis in the Emergency Department: Room for Improvement.

Hesham Abboud, Karin Mente, Meagan Seay, Jeffrey Kim, Ashhar Ali, Robert Bermel, Mary A Willis.   

Abstract

BACKGROUND: Patients with multiple sclerosis (MS) present to the emergency department (ED) for various reasons. Although true relapse is rarely the underlying culprit, ED visits commonly result in new magnetic resonance imaging (MRI) and neurology admissions. We studied ED visits in patients with MS and evaluated decision making regarding diagnostic/therapeutic interventions and visit outcomes. We identified potential areas for improvement and used the data to propose a triaging algorithm for patients with MS in the ED.
METHODS: We reviewed the medical records from 176 ED visits for patients with MS in 2014.
RESULTS: Ninety-seven visits in 75 patients were MS related (66.6% female; mean ± SD age, 52.6 ± 13.8 years; mean ± SD disease duration, 18.5 ± 10.5 years). Thirty-three visits were for new neurologic symptoms (category 1), 29 for worsening preexisting symptoms (category 2), and 35 for MS-related complications (category 3). Eighty-nine visits (91.8%) resulted in hospital admission (42.7% to neurology). Only 39% of ordered MRIs showed radiographic activity. New relapses were determined in 27.8% of the visits and were more prevalent in category 1 compared with category 2 (P = .003); however, the two categories had similar rates of ordered MRIs and neurology admissions.
CONCLUSIONS: New relapse is a rare cause of ED visits in MS. Unnecessary MRIs and neurology admissions can be avoided by developing a triaging system for patients with MS based on symptom stratification.

Entities:  

Year:  2017        PMID: 29270086      PMCID: PMC5734712          DOI: 10.7224/1537-2073.2016-069

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  14 in total

1.  Uhthoff's syndrome.

Authors:  G D Perkin; F C Rose
Journal:  Br J Ophthalmol       Date:  1976-01       Impact factor: 4.638

Review 2.  Implications for multiple sclerosis in the era of the Affordable Care Act: a clinical overview.

Authors:  Megan Maroney; Samuel F Hunter
Journal:  Am J Manag Care       Date:  2014-12       Impact factor: 2.229

3.  Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database.

Authors:  Jeff D Prescott; Saul Factor; Michael Pill; Gary W Levi
Journal:  J Manag Care Pharm       Date:  2007 Jan-Feb

4.  Socioeconomic trends in hospitalization for multiple sclerosis.

Authors:  Shivanand P Lad; Christopher H Chapman; Michael Vaninetti; Lawrence Steinman; Ari Green; Maxwell Boakye
Journal:  Neuroepidemiology       Date:  2010-06-15       Impact factor: 3.282

5.  A comprehensive assessment of the cost of multiple sclerosis in the United States.

Authors:  K Whetten-Goldstein; F A Sloan; L B Goldstein; E D Kulas
Journal:  Mult Scler       Date:  1998-10       Impact factor: 6.312

6.  Impact of Proactive Case Management by Multiple Sclerosis Specialist Nurses on Use of Unscheduled Care and Emergency Presentation in Multiple Sclerosis: A Case Study.

Authors:  Alison Leary; Debbie Quinn; Amy Bowen
Journal:  Int J MS Care       Date:  2015 Jul-Aug

7.  Health care costs of veterans with multiple sclerosis: implications for the rehabilitation of MS. VA Multiple Sclerosis Rehabilitation Study Group.

Authors:  D N Bourdette; A V Prochazka; W Mitchell; P Licari; J Burks
Journal:  Arch Phys Med Rehabil       Date:  1993-01       Impact factor: 3.966

8.  Emergency medical care of multiple sclerosis patients: primary data from the mount sinai resource utilization in multiple sclerosis project.

Authors:  Svenja Oynhausen; Megan Alcauskas; Christine Hannigan; Yadira Bencosme; Marcus Müller; Fred Lublin; Stephen Krieger
Journal:  J Clin Neurol       Date:  2014-07-03       Impact factor: 3.077

9.  Cost of managing an episode of relapse in multiple sclerosis in the United States.

Authors:  Judith A O'Brien; Alexandra J Ward; Amanda R Patrick; Jaime Caro
Journal:  BMC Health Serv Res       Date:  2003-09-02       Impact factor: 2.655

10.  Association Between Urinary Symptoms and Urinary Tract Infection in Patients With Multiple Sclerosis.

Authors:  Alireza Nikseresht; Haideh Salehi; Amin Abolhasani Foroughi; Masoumeh Nazeri
Journal:  Glob J Health Sci       Date:  2015-09-28
View more
  5 in total

1.  Multiple Sclerosis Wellness Shared Medical Appointment Model: A Pilot Study.

Authors:  Justin R Abbatemarco; Jeffrey A Cohen; Belinda L Udeh; Sunakshi Bassi; Mary R Rensel
Journal:  Int J MS Care       Date:  2021-04-08

2.  Evaluation of Urinary Tract Infection following Corticosteroid Therapy in Patients with Multiple Sclerosis Exacerbation.

Authors:  Aliyeh Bazi; Seyed Mohammad Baghbanian; Monireh Ghazaeian; Sahar Fallah; Narjes Hendoiee
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-01-31       Impact factor: 2.471

Review 3.  Characterizing and quantifying low-value diagnostic imaging internationally: a scoping review.

Authors:  Elin Kjelle; Eivind Richter Andersen; Arne Magnus Krokeide; Lesley J J Soril; Leti van Bodegom-Vos; Fiona M Clement; Bjørn Morten Hofmann
Journal:  BMC Med Imaging       Date:  2022-04-21       Impact factor: 2.795

4.  Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis.

Authors:  Jagadeswara Rao Earla; George J Hutton; J Douglas Thornton; Hua Chen; Michael L Johnson; Rajender R Aparasu
Journal:  Explor Res Clin Soc Pharm       Date:  2021-05-05

5.  Emergency department use by persons with MS: A population-based descriptive study with a focus on infection-related visits.

Authors:  Jonas Graf; Huah Shin Ng; Feng Zhu; Yinshan Zhao; José Ma Wijnands; Charity Evans; John D Fisk; Ruth Ann Marrie; Helen Tremlett
Journal:  Mult Scler       Date:  2022-03-01       Impact factor: 5.855

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.